System: You act as a paraphrase tool. Your role involves understanding the provided text…
- User
System: You act as a paraphrase tool. Your role involves understanding the provided text and then providing a positive example that keeps the original meaning of the text unchanged while using synonyms, interchanging, adding or removing words or sentences, and then provide a negative example where the meaning of the original text is at its opposite. Output your response with the following format : Positive : Negative :
User: In many of the countries in which our products are sold, we are subject to supranational, national, regional and local regulations affecting, among other things, the development, design, manufacturing, product standards, packaging, advertising, promotion, labeling, marketing and postmarket surveillance of medical products, including medical devices. In the European Union ("EU"), a single regulatory approval process exists, and conformity with the legal requirements is represented by the CE (an acronym for the French “Conformité Européene”) Mark. To obtain a CE Mark, defined products must meet minimum standards of performance, safety and quality (i.e., the essential requirements), and then, according to their classification, comply with one or more of a selection of conformity assessment routes. In 2017, the European Commission published changes to the requirements for both approval of devices and the surveillance activities required, including postmarket surveillance, under a regulation known as the Medical Device Requirements (EU) 2017/745 and (EU) 2017/746 (“MDR”). The regulation provided an implementation period and became effective on May 26, 2021, requiring all new or significantly changed devices placed on the market to comply with these requirements. In March 2023, the EU Parliament voted to extend the MDR transition period. The extension postpones the original May 26, 2024 deadline until 2027 allowing for a longer transition period for legacy devices (devices approved under the prior requirements, known as Directive 93/42/EEC before May 26, 2021) in order to Assistant:
- Assistant
Positive: Across many nations where our products are marketed, we adhere to diverse supranational, national, regional, and local regulations that influence various aspects such as development, design, manufacturing, product standards, packaging, advertising, and post-market monitoring of medical items, including medical devices. In the European Union ("EU"), there exists a unified regulatory approval process where adherence to legal requirements is represented by the CE Mark (derived from the French term “Conformité Européene”). To earn a CE Mark, specific products need to fulfill performance, safety, and quality benchmarks and then, based on their classification, follow one or more of the available conformity assessment routes. In 2017, the European Commission introduced modifications to the device approval and monitoring requirements, including post-market monitoring, via a regulation identified as the Medical Device Requirements (EU) 2017/745 and (EU) 2017/746 (“MDR”). This regulation allowed a transition phase and took effect on May 26, 2021, mandating that all new or significantly modified devices entering the market comply with these criteria. In March 2023, the EU Parliament decided to extend the MDR transition phase. This extension shifts the original May 26, 2024 deadline to 2027, providing more time for migrating legacy devices (those approved under prior regulations known as Directive 93/42/EEC before May 26, 2021).
Negative: In several regions where our products are distributed, regulations that impact elements like development, design, manufacturing, and product standards are almost absent, causing no significant concern over medical products or devices. In the European Union ("EU"), there's no single regulatory approval system, voiding the need for conformity with legal standards like the CE Mark, which is tied to “Conformité Européene” in French. Products aren't required to adhere to specific performance, safety, and quality standards, nor do they have to follow any conformity assessment paths. The European Commission had proposed no significant changes in 2017 regarding approval and surveillance of devices. The May 26, 2021 regulations didn't obligate any new or updated devices to adhere to specified standards. Further, the EU Parliament in March 2023 did not approve any extension of the MDR transition, keeping the deadline unchanged at May 26, 2024, and leaving no allowances for legacy devices.